Nanomaterials for Drug Delivery: Current Status and Future Prospects
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Nanomedicine and Nanobiology".
Deadline for manuscript submissions: 30 June 2026
Special Issue Editors
Interests: polymer chemistry; molecular imaging probes; nanomedicines; prodrugs; aggregation-induced emission; fluorescence imaging; photoacoustic imaging; microscopy; wide-field imaging; two photon imaging; second harmonic imaging
Special Issues, Collections and Topics in MDPI journals
Interests: nanomaterials for drug delivery; metal–organic frameworks (MOFs); porous nanomaterials; polymeric nanocarriers; inorganic nanoparticles; hybrid nanomaterials; controlled and targeted drug release; stimuli-responsive delivery systems; inhalable and injectable nanocarriers; bioimaging-guided therapy; nanomedicine; translational drug delivery platforms
Special Issue Information
Dear Colleagues,
Nanomaterials have revolutionized modern drug delivery by enabling precise control over therapeutic loading, release profiles, biodistribution, and targeting efficiency. Among these, MOFs, porous inorganic materials, polymer-based nanocarriers, and hybrid multifunctional systems offer unprecedented tunability in structure, chemistry, and responsiveness. This Special Issue aims to showcase recent advances in the design, fabrication, and biomedical application of diverse nanomaterials for controlled and targeted drug delivery. Particular emphasis will be placed on biocompatible, stimuli-responsive platforms engineered for improved therapeutic efficacy, including systems triggered by pH, redox gradients, enzymes, temperature, or NIR light. We also welcome contributions that explore smart nanocarriers capable of overcoming biological barriers, enabling inhalable or systemic delivery, integrating diagnostic imaging, or supporting precision medicine approaches. Both fundamental studies—such as drug–carrier interactions, release mechanisms, and degradation pathways—and applied investigations involving in vitro and in vivo evaluations are encouraged. This Special Issue aims to provide a comprehensive and forward-looking overview of nanomaterials-based drug delivery technologies and their future prospects in clinical translation.
Dr. Bing Guo
Dr. Madappa C. Maridevaru
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanomaterials for drug delivery
- metal–organic frameworks (MOFs)
- porous nanomaterials
- polymeric nanocarriers
- inorganic nanoparticles
- hybrid drug delivery systems
- controlled drug release
- targeted delivery
- stimuli-responsive nanocarriers
- biocompatible nanoplatforms
- theranostics
- precision nanomedicine
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
